Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (331-340 of 669) with videos related to

Pageof 67
Sort By:
Antimicrobial Agents and Chemotherapy|August 20, 2008
Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmidsJing-Cao Pan, Rong Ye, Hao-Qiu Wang, et al.
Journal of Cellular Biochemistry|March 8, 2017
GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug ResistancePranav Gupta, Meina Xie, Silpa Narayanan, et al.
Oncotarget|March 12, 2015
High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosisZhi-Liang Huang, Zhi-Rui Lin, Yi-Ren Xiao, et al.
Nature Reviews. Clinical Oncology|July 30, 2025
Understanding and overcoming multidrug resistance in cancerMinghua Ge, Xuan-Yu Chen, Ping Huang, et al.
Chinese Journal of Cancer|June 26, 2017
Autophagy and multidrug resistance in cancerYing-Jie Li, Yu-He Lei, Nan Yao, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2013
PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cellsAtish Patel, Amit K Tiwari, Eduardo E Chufan, et al.
Experimental Cell Research|April 3, 2020
Plasminogen activator inhibitor (PAI) trap3, an exocellular peptide inhibitor of PAI-1, attenuates the rearrangement of F-actin and migration of cancer cellsJihao Liu, Zhuo Chen, Mingdong Huang, et al.
Molecular Cancer Therapeutics|July 11, 2012
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, et al.
Oncology Reports|June 18, 2002
Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cellsMotoi Mukai, Atsuko Kanzaki, Zhe-Sheng Chen, et al.
Biochemical Pharmacology|February 26, 2014
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoKamlesh Sodani, Atish Patel, Nagaraju Anreddy, et al.
Pageof 67

Showing results (331-340 of 669) with videos related to

Sort By:
Pageof 67
Antimicrobial Agents and Chemotherapy|August 20, 2008
Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmidsJing-Cao Pan, Rong Ye, Hao-Qiu Wang, et al.
Journal of Cellular Biochemistry|March 8, 2017
GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug ResistancePranav Gupta, Meina Xie, Silpa Narayanan, et al.
Oncotarget|March 12, 2015
High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosisZhi-Liang Huang, Zhi-Rui Lin, Yi-Ren Xiao, et al.
Nature Reviews. Clinical Oncology|July 30, 2025
Understanding and overcoming multidrug resistance in cancerMinghua Ge, Xuan-Yu Chen, Ping Huang, et al.
Chinese Journal of Cancer|June 26, 2017
Autophagy and multidrug resistance in cancerYing-Jie Li, Yu-He Lei, Nan Yao, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2013
PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cellsAtish Patel, Amit K Tiwari, Eduardo E Chufan, et al.
Experimental Cell Research|April 3, 2020
Plasminogen activator inhibitor (PAI) trap3, an exocellular peptide inhibitor of PAI-1, attenuates the rearrangement of F-actin and migration of cancer cellsJihao Liu, Zhuo Chen, Mingdong Huang, et al.
Molecular Cancer Therapeutics|July 11, 2012
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, et al.
Oncology Reports|June 18, 2002
Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cellsMotoi Mukai, Atsuko Kanzaki, Zhe-Sheng Chen, et al.
Biochemical Pharmacology|February 26, 2014
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoKamlesh Sodani, Atish Patel, Nagaraju Anreddy, et al.
Pageof 67